National Webinar - Biosimilar Policy to Practice: Key Learnings, Existing Resources and Projected Savings

National Webinar - Biosimilar Policy to Practice: Key Learnings, Existing Resources and Projected Savings

June 22, 2021 12:00 PM to 1:30 PMOnline - Eastern Time Zone
Area of Interest: Benefits Format: Web

This session is designed to help employers and their advisors implement and manage a biosimilar switching policy. Dr. Kerri Novak, Clinical Associate Professor of Medicine, Division of Gastroenterology and Hepatology will prat the University of Calgary will pesent the rationale and evidence for transitioning patients, her own experiences in Alberta, and share her approach and perspective for patients. Dr. Anar Dossa,  Director, Pharmacy Services at Pacific Blue Cross will describe British Columbia's ground-breaking Biosimilar Initiative and how Pacific Blue Cross planned and engaged their clients over the last 18 months to take advantage of significant savings.

Our panelists will share their first-hand experience in planning, communicating, implementing, and monitoring a successful biosimilar transition. The discussion will be moderated by Chris Bonnett, Principal Consultant at H3 Consulting.

This session will include survey results of plan members, physicians and pharmacists, as well as financial impacts and helpful, high quality educational resources.

Attend to:

Engage with leaders who have already implemented an impactful biosimilar policy in Canada. These experts can share their knowledge, experience and existing resources as part of a package of information for participants.

Who should attend:

Employers and advisors who are interested in or actively planning to implement a biosimilar transition policy, who want to better understand plan member experience and satisfaction, and take advantage of important savings that help make drug benefit plans more sustainable.


.

Already Registered? You can login, 15 minutes before start time, using your email from here: 

Login to view the live 

Fees and Registration
Membership TypesRegular PricePlan Sponsor Price
Regular membership$0.00 CDN$0.00 CDN
Plan Sponsor Individual Membership$0.00 CDN$0.00 CDN
Associate$0.00 CDN$0.00 CDN
Student$0.00 CDN -
Non Member$65.00 CDN$50.00 CDN
Cancellation Policy
CE credits are offered in partnership with, The Institute (advocis), Manitoba, Saskatchewan, Alberta and BC insurance council


SPEAKERS__________________________________________MODERATOR

Anar Dossa BScPharm Pharm D CDE
Director, Pharmacy Services
Pacific Blue Cross

Dr. Kerri Novak MD MSc FRCPC
Clinical Associate Professor of Medicine, Division of Gastroenterology and Hepatology
University of Calagary

Chris Bonnett, MHSc, PhD
Principal Consultant, H3 Consulting

Anar Dossa is the Director of Pharmacy Services at Pacific Blue Cross.  She has over 30 years of experience in applying evidence informed decisions into daily practice.

She is currently the Chair of the Prescription Drug Committee, CLHIA, Clinical Assistant Professor in the Faculty of Pharmaceutical Sciences at UBC, and Past Chair, College of Pharmacists of BC.

Dr. Novak is an academic gastroenterologist at the University of Calgary with a special interest in small bowel imaging using ultrasound in inflammatory bowel disease. Inspired while working in gastrointestinal radiology in Calgary, Dr. Kerri Novak, MD, pursued training in intestinal ultrasound (IUS) in Germany in 2012. She returned to Calgary to establish the first inflammatory bowel disease (IBD) clinic in Canada to provide routine IUS for patients with IBD.

She is the Deputy Division head, Division of Gastroenterology and Hepatology and is the Medical Lead of Quality Improvement at the University of Calgary. Kerri is passionate about improving the health system, and ensuring patients are heard and recognized to make the journey in their path to health better.

Chris Bonnett established H3 Consulting in 1999, after 18 years of progressive experience in underwriting, reinsuring, selling, and marketing employee benefits. He provides practical prescription drug policy research for private and public drug plan leaders, and consults on workplace health strategy. He speaks and writes frequently on these topics.

Chris has been a volunteer director on the Boards of four health organizations. He is a sessional Professor in workplace health at Humber College, and is on the Advisory Board of the Sanofi Canada Healthcare Survey. He holds a Master's degree in Health Science from the University of Toronto, and a PhD in drug policy from the University of Waterloo.




Moderator:



By continuing to use this website, you are agreeing to our use of cookies.